ESSA PHARMA INC's ticker is and the CUSIP is 29668H104. A total of 1 filers reported holding ESSA PHARMA INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 3.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $1,935,000 | – | 10,183,646 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Clarus Ventures, LLC | 2,121,212 | $6,618,000 | 4.93% |
| Omega Fund Management, LLC | 1,696,969 | $5,295,000 | 3.44% |
| AWM Investment Company, Inc. | 3,393,936 | $10,590,000 | 0.99% |
| Eventide Asset Management | 2,719,410 | $7,411,000 | 0.49% |
| ACUTA CAPITAL PARTNERS, LLC | 605,300 | $1,876,000 | 0.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,121,601 | $6,619,000 | 0.26% |
| TORONTO DOMINION BANK | 62 | $0 | 0.00% |
| BANK OF MONTREAL /CAN/ | 1,000 | $3,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 400 | $1,000 | 0.00% |
| ROYAL BANK OF CANADA | 6,200 | $19,000 | 0.00% |